You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金達威(002626.SZ):子公司等擬投設金達威生物技術(江蘇)
格隆匯 03-10 16:34

格隆匯3月10日丨金達威(002626.SZ)公佈,為提高企業核心競爭力,貫徹技術創新,推動企業進步,帶動產業升級,公司全資子公司內蒙古金達威藥業有限公司(“金達威藥業)廈門金達威維生素有限公司(金達威維生素)、公司控股子公司江蘇誠信藥業有限公司(誠信藥業)北京樺冠生物技術有限公司(樺冠),經商談後於202139福建廈門簽署《投資協議》,在江蘇省啟東市共同投資設立合資公司金達威生物技術(江蘇)有限公司(暫定名)(合資公司),資公司註冊資本為人民幣1億元,其中金達威藥業擬以自有資金出資4700萬元,持有合資公司47%的股權,金達威維生素擬以自有資金出資2500萬元,持有合資公司25%的股權,誠信藥業擬以自有資金出資2000萬元,持有合資公20%的股權,樺冠擬以自有資金出資800萬元,持有合資公司8%的股權。

公司一貫堅持強化創新、引領未來的原則,建立以企業為主體、市場為導向、產學研一體化的技術研發和創新體系並擁有國家企業技術中心多年來,通過原始創新、集成創新和引進消化吸收再創新,形成了微生物發酵、化合成、天然產物提取、膠囊製備四大核心技術,實現了系列產品生產技術的全面提升。合資公司成立後,有利於進一步提高公司科學研發與自主研發的能力,對公司的新品開發、技術創新、長遠發展和企業效益將產生積極影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account